GLBICYLAZYRDLW-UHFFFAOYSA-N
C27H26F3N7O4 — CID 146219715
Data last refreshed: (MolForge compound catalog, from PubChem)
About GLBICYLAZYRDLW-UHFFFAOYSA-N
GLBICYLAZYRDLW-UHFFFAOYSA-N (PubChem CID 146219715) has the molecular formula C27H26F3N7O4 and a molecular weight of 569.54 g/mol. Its IUPAC name is 6-[4-[2-[2-[[2-[6-oxo-5-(trifluoromethyl)-1H-pyridazin-4-yl]-1,3-dihydroisoindol-4-yl]oxy]ethoxy]acetyl]piperazin-1-yl]pyridine-3-carbonitrile.
Molecular Properties
| Compound Name | GLBICYLAZYRDLW-UHFFFAOYSA-N |
|---|---|
| PubChem CID | 146219715 |
| Molecular Formula | C27H26F3N7O4 |
| Molecular Weight | 569.54 g/mol |
| Exact Mass | 569.20 |
| IUPAC Name | 6-[4-[2-[2-[[2-[6-oxo-5-(trifluoromethyl)-1H-pyridazin-4-yl]-1,3-dihydroisoindol-4-yl]oxy]ethoxy]acetyl]piperazin-1-yl]pyridine-3-carbonitrile |
| SMILES | N#Cc1ccc(N2CCN(C(=O)COCCOc3cccc4c3CN(c3cn[nH]c(=O)c3C(F)(F)F)C4)CC2)nc1 |
| InChI | InChI=1S/C27H26F3N7O4/c28-27(29,30)25-21(14-33-34-26(25)39)37-15-19-2-1-3-22(20(19)16-37)41-11-10-40-17-24(38)36-8-6-35(7-9-36)23-5-4-18(12-31)13-32-23/h1-5,13-14H,6-11,15-17H2,(H,34,39) |
| InChIKey | GLBICYLAZYRDLW-UHFFFAOYSA-N |
| XLogP | 2.32 |
| TPSA | 127.68 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 9 |
| Rotatable Bonds | 8 |
| Heavy Atoms | 41 |
| Complexity | — |
Lipinski Rule of Five
1 violation
| Rule | Value |
|---|---|
| MW ≤ 500 | 569.54 |
| LogP ≤ 5 | 2.32 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 9 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 146219715 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.